AAPM&R Members in the News: October 2017
AAPM&R Submits Comments to AMA on Burdensome Certification and LCD Requirements
AAPM&R Submits Comments on CMS Proposed Rule: Cancellation of Advancing Care Coordination
Octagam [Immune Globulin Intravenous (human)] 10 Percent Liquid Preparation]: Voluntary Market Withdrawal
Injectable Products by SCA Pharmaceuticals: Recall - Potential Contamination
URGENT – Voluntary Market Withdrawal – October 13, 2017: octagam [Immune Globulin Intravenous (human)] 10% Liquid Preparation]
Participate in an Online Survey to Test MACRA Episode-Based Cost Measures
AAPM&R and Coalition to Preserve Rehabilitation Call for CMS to Rescind Home Health Proposed Rule
Centers for Disease Control and Prevention (CDC) Solicits Public Comments for Draft Guideline and Systematic Review on Pediatric Mild TBI
Darryl L. Kaelin, MD Assumes AAPM&R Presidency
Registry Participant Spotlight: Riverbend Physical Medicine and Rehabilitation
AAPM&R Endorses the American Society of Anesthesiologists’ (ASA) Perioperative Surgical Home (PSH) Model
Now Available: Qualifying APM Participant Look-Up Tool
Look for Your October/November Issue of The Physiatrist
Congress Misses Sept 30 Deadline to Renew the Children’s Health Insurance Program (CHIP)
NEW Cancer Rehabilitation Supplement and SAE-P
AAPM&R Submits Comments to CMS for Medicare Physician Fee Schedule
IRF and LTCH Provider Preview Reports: Final Days to Review Your Data
MIPS Milestone: Begin Data Collection by October 2nd for 90 Consecutive Days of Participation
CMS to Conduct Episode-Based Cost Measure Field Testing